Katie Shannon’s story: The colleague behind facility construction

The missing element is personalization


The need for viral vector production is growing quickly, driven by their crucial role in gene therapies. However, there exists a notable gap in commercial manufacturing capabilities. Thermo Fisher is committed to meeting this need, spearheading the establishment of state-of-the-art facilities.

At the forefront of this challenge is Katie Shannon, who’s been instrumental in navigating these construction projects. By collaborating closely with drug developers, Katie ensures that all project timelines are fulfilled, ultimately advancing the delivery of novel gene therapies to patients in need.

Watch Katie’s story to learn about her role at Thermo Fisher, where her signature attire is a professional blazer on top and construction boots on bottom. Together with our partners, she’s tailoring our facilities for viral vector production, accommodating diverse sizes and scales of processes and platforms.